Radiosynthesis and Radiotracer Properties of a 7-(2-[18F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET

Autor: Maisonial-Besset, Aurélie, Funke, Uta, Deuther-Conrad, Winnie, Schwan, Gregor, Maisonial, Aurélie, Scheunemann, Matthias, Fischer, Steffen, Hiller, Achim, Briel, Detlef, Brust, Peter
Přispěvatelé: Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Institute of Radiopharmacy, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Synthèse et étude de systèmes à intêret biologique (SEESIB), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Zdroj: Pharmaceuticals Policy and Law
Pharmaceuticals Policy and Law, IOS Press, 2012, 5 (12), pp.169-188. ⟨10.3390/ph5020169⟩
Pharmaceuticals
Pharmaceuticals, Vol 5, Iss 2, Pp 169-188 (2012)
Pharmaceuticals; Volume 5; Issue 2; Pages: 169-188
Pharmaceuticals Policy and Law, 2012, 5 (12), pp.169-188. ⟨10.3390/ph5020169⟩
ISSN: 1389-2827
Popis: Phosphodiesterase 10A (PDE10A) is a key enzyme of intracellular signal transduction which is involved in the regulation of neurotransmission. The molecular imaging of PDE10A by PET is expected to allow a better understanding of physiological and pathological processes related to PDE10A expression and function in the brain. The aim of this study was to develop a new 18F-labeled PDE10A ligand based on a 6,7-dimethoxy-4-pyrrolidinylquinazoline and to evaluate its properties in biodistribution studies. Nucleophilic substitution of the 7-tosyloxy-analogue led to the 7-[18F]fluoroethoxy-derivative [18F]IV with radiochemical yields of 25% ± 9% (n = 9), high radiochemical purity of ≥99% and specific activities of 110–1,100 GBq/μmol. [18F]IV showed moderate PDE10A affinity (KD,PDE10A = 14 nM) and high metabolic stability in the brain of female CD-1 mice, wherein the radioligand entered rapidly with a peak uptake of 2.3% ID/g in striatum at 5 min p.i. However, ex vivo autoradiographic and in vivo blocking studies revealed no target specific accumulation and demonstrated [18F]IV to be inapplicable for imaging PDE10A with PET.
Databáze: OpenAIRE